AP739A - Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity. - Google Patents

Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity. Download PDF

Info

Publication number
AP739A
AP739A APAP/P/1997/000989A AP9700989A AP739A AP 739 A AP739 A AP 739A AP 9700989 A AP9700989 A AP 9700989A AP 739 A AP739 A AP 739A
Authority
AP
ARIPO
Prior art keywords
erythromycin
formula
oxime
ethyl
compounds
Prior art date
Application number
APAP/P/1997/000989A
Other languages
English (en)
Other versions
AP9700989A0 (en
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of AP9700989A0 publication Critical patent/AP9700989A0/xx
Application granted granted Critical
Publication of AP739A publication Critical patent/AP739A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
APAP/P/1997/000989A 1994-12-13 1995-12-07 Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity. AP739A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (2)

Publication Number Publication Date
AP9700989A0 AP9700989A0 (en) 1997-07-31
AP739A true AP739A (en) 1999-03-24

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1997/000989A AP739A (en) 1994-12-13 1995-12-07 Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity.

Country Status (35)

Country Link
US (1) US5847092A (xx)
EP (1) EP0797579B1 (xx)
JP (1) JPH10510520A (xx)
KR (1) KR100367559B1 (xx)
CN (1) CN1046535C (xx)
AP (1) AP739A (xx)
AT (1) ATE190620T1 (xx)
AU (1) AU690791B2 (xx)
BG (1) BG63261B1 (xx)
BR (1) BR9510015A (xx)
CA (1) CA2207029A1 (xx)
CZ (1) CZ289943B6 (xx)
DE (1) DE69515694T2 (xx)
DK (1) DK0797579T3 (xx)
EE (1) EE03401B1 (xx)
ES (1) ES2144154T3 (xx)
FI (1) FI972493A (xx)
GE (1) GEP20012391B (xx)
GR (1) GR3033622T3 (xx)
HU (1) HU220631B1 (xx)
IT (1) IT1276901B1 (xx)
LT (1) LT4276B (xx)
LV (1) LV11898B (xx)
MD (1) MD1788G2 (xx)
NO (1) NO309816B1 (xx)
NZ (1) NZ297446A (xx)
OA (1) OA10491A (xx)
PL (1) PL182053B1 (xx)
PT (1) PT797579E (xx)
RO (1) RO116282B1 (xx)
RU (1) RU2152951C1 (xx)
SI (1) SI9520124A (xx)
TJ (1) TJ306B (xx)
UA (1) UA48958C2 (xx)
WO (1) WO1996018633A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) * 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
JP5383037B2 (ja) 2004-02-27 2014-01-08 リブ−エックス ファーマシューティカルズ，インコーポレイテッド 大環状化合物およびそれらを製造し使用する方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033255A1 (fr) * 1980-01-11 1981-08-05 Roussel-Uclaf Nouvelles oximes dérivées de l'érythromycine A, leur préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP0487411A1 (fr) * 1990-11-21 1992-05-27 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation, les nouveaux intermédiaires obtenus et leur application comme médicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
DK90788A (da) 1987-02-24 1988-08-25 Beecham Group Plc Erythromycinderivater
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0033255A1 (fr) * 1980-01-11 1981-08-05 Roussel-Uclaf Nouvelles oximes dérivées de l'érythromycine A, leur préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP0487411A1 (fr) * 1990-11-21 1992-05-27 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation, les nouveaux intermédiaires obtenus et leur application comme médicaments

Also Published As

Publication number Publication date
HU220631B1 (hu) 2002-03-28
FI972493A0 (fi) 1997-06-12
GEP20012391B (en) 2001-03-25
IT1276901B1 (it) 1997-11-03
MD1788F2 (en) 2001-11-30
MD1788G2 (ro) 2002-05-31
NZ297446A (en) 1999-06-29
AU690791B2 (en) 1998-04-30
EE03401B1 (et) 2001-04-16
FI972493A (fi) 1997-06-12
DE69515694D1 (de) 2000-04-20
ITMI942496A0 (it) 1994-12-13
HUT77126A (hu) 1998-03-02
US5847092A (en) 1998-12-08
EE9700124A (et) 1997-12-15
LT4276B (lt) 1998-01-26
EP0797579B1 (en) 2000-03-15
PT797579E (pt) 2000-08-31
ES2144154T3 (es) 2000-06-01
TJ306B (en) 2001-08-06
MD970243A (en) 1999-05-31
SI9520124A (sl) 1998-04-30
JPH10510520A (ja) 1998-10-13
CZ289943B6 (cs) 2002-04-17
CN1169727A (zh) 1998-01-07
GR3033622T3 (en) 2000-10-31
RO116282B1 (ro) 2000-12-29
OA10491A (en) 2002-04-10
LV11898A (lv) 1997-12-20
RU2152951C1 (ru) 2000-07-20
KR100367559B1 (ko) 2003-04-21
BR9510015A (pt) 1997-10-28
PL182053B1 (pl) 2001-10-31
BG101570A (en) 1998-02-27
CA2207029A1 (en) 1996-06-20
WO1996018633A1 (en) 1996-06-20
AP9700989A0 (en) 1997-07-31
LT97116A (en) 1997-10-27
CN1046535C (zh) 1999-11-17
PL320688A1 (en) 1997-10-27
ITMI942496A1 (it) 1996-06-13
UA48958C2 (uk) 2002-09-16
LV11898B (en) 1998-03-20
NO972702L (no) 1997-08-13
CZ178697A3 (en) 1997-12-17
DK0797579T3 (da) 2000-06-05
ATE190620T1 (de) 2000-04-15
NO972702D0 (no) 1997-06-12
MX9704253A (es) 1997-09-30
DE69515694T2 (de) 2000-10-26
NO309816B1 (no) 2001-04-02
AU4260396A (en) 1996-07-03
BG63261B1 (bg) 2001-07-31
EP0797579A1 (en) 1997-10-01

Similar Documents

Publication Publication Date Title
JP2657132B2 (ja) アジスロマイシンａのｏ−メチル誘導体、その製造法、その製造中間体及びそれを含有する抗菌剤組成物
KR100486053B1 (ko) 신규에리트로마이신유도체,그의제조방법및약제로서의그의용도
SK285535B6 (sk) 6-O-Substituované ketolidy s antibakteriálnou aktivitou, farmaceutická kompozícia s ich obsahom, ich použitie a spôsob ich prípravy
HU193886B (en) Process for preparing epimer azahomoerythromycin a derivatives
AP739A (en) Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity.
RU2320668C2 (ru) 9а-азалиды с противовоспалительной активностью
EA005156B1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
BG64650B1 (bg) 9а-азалиди
FI72322B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara marolider
GB2135670A (en) C-20- and c-23-modified macrolide derivatives
EP1414835B1 (en) 9a-n-[n'-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a and of 5-o-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide a
RU2328503C2 (ru) N''-ЗАМЕЩЕННЫЕ 9a-N-(N'-КАРБАМОИЛ-ГАММА-АМИНОПРОПИЛЬНЫЕ) И 9a-N-(N'-ТИОКАРБАМОИЛ-ГАММА-АМИНОПРОПИЛЬНЫЕ), ПРОИЗВОДНЫЕ 9-ДЕЗОКСО-9-ДИГИДРО-9a-АЗА-9a-ГОМОЭРИТРОМИЦИНА A И 5-O-ДЕЗОЗАМИНИЛ-9-ДЕЗОКСО-9-ДИГИДРО-9a-АЗА-9a-ГОМОЭРИТРОНОЛИДА A
DE602004010110T2 (de) Neue 14- und 15-gliedrige ringverbindungen
MXPA97004253A (en) Derivatives of 9-0-oxima of erythromycin or dotated with antibioot activity
JP3227871B2 (ja) ６−ｏ−メチルエリスロマイシンａ誘導体
JP2000198795A (ja) エリスロマイシンａ誘導体
EP1100806B1 (en) Erythromycin derivative with antibiotic activity